From the Writing
Newspaper La Jornada
Monday, August 22, 2022, p. 16
Cofepris warned about the marketing of counterfeit and expired drugs against breast cancer and diabetes. Their use can harm health, and he asked the population to verify them in case of using them.
Of Perjeta, against breast cancer, in lots H0343B08, V4322H37 and H0498B16, with a concentration of 420mg/14ml solution, counterfeit products have been identified that put those who are under treatment with this oncology at risk, since the good manufacturing practices or the quality and safety of its ingredients, it said.
Ask to check the lot number and the box, as it presents texts near the fold line at the top, absence of legends below the formula and texts in English. It also reported that Forxiga’s batch LM0204, for diabetes control, expired in August 2021, data that was covered to place the denomination MJ0017 with a false expiration date of June 2022.